.png)
In biopharma, SKUs multiply quickly.
Different pack sizes.
Dosage variations.
Country-specific labelling.
Tender-driven requirements.
But every additional SKU adds:
More inventory exposure.
More cold-chain complexity.
More expiry risk.
The question isn’t how many SKUs you can support, it is which ones actually create value across service, cost, and cash.
Goldiilocks helps teams evaluate each SKU in context, so portfolio growth doesn’t quietly increase financial or patient risk.


.png)

.png)
Oii.ai enables organisations to consistently achieve the perfect supply chain planning set up to meet their strategic goals and maximise profit.